Literature DB >> 239103

Intestinal absorption of cytidine diphosphate choline and its changes in the digestive tract.

K Yashima, M Takamatsu, K Okuda.   

Abstract

Intestinal absorption of cytidine diphosphate choline (CDP-choline), its structural changes in the digestive tract, and hepatic uptake have been investigated in rats using 14C-labeled (14CH3 attached to N of choline) and 3H-labeled (at C5 of pyrimidine) compounds. The results indicate that: 1)CDP-choline is relatively stable in the stomach, but is quickly degraded into cytidine and choline in the intestine; 2) The hepatic uptakes of 14C and 3H reach the maximum in two to three hours after oral administration; 3) Whereas the amount of 14C remaining in the gut is inversely related to the hepatic uptake, no similar correlation is seen with 3H-labeled CDP-choline, and 4) Extrahepatic uptake of 14C and 3H is very small. The possibility of phosphorylation in the mucosa of choline and cytidine has been discussed, based on the differences in individual broken-down products in the intestinal lumen and mucosa.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239103     DOI: 10.3177/jnsv.21.49

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  3 in total

1.  Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy.

Authors:  S M Babb; K E Appelmans; P F Renshaw; R J Wurtman; B M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice.

Authors:  R Giménez; J Raïch; J Aguilar
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

Review 3.  Neuroprotective properties of citicoline: facts, doubts and unresolved issues.

Authors:  Pawel Grieb
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.